Editorial
World J Hepatol
16(1):1-11.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.1
Abstract (700)
|
Core Tip (786)
|
Full Article (HTML) (2588)
|
Figures (1-1) (521)
|
Full Article (PDF)-1204K (218)
|
Full Article with Cover (PDF)-11949K (260)
|
Full Article (XML)-236K (140)
|
Audio-1342K (11)
|
Peer-Review Report-230K (151)
|
Answering Reviewers-97K (139)
|
Received: 10/26/2023
|
Revised: 12/04/2023
|
Accepted: 12/28/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (8193)
|
Similar Articles (78)
|
Timeline of Article Publication (1)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):12-16.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.12
Abstract (737)
|
Core Tip (781)
|
Full Article (HTML) (1875)
|
Tables (1-1) (595)
|
Full Article (PDF)-358K (179)
|
Full Article with Cover (PDF)-11106K (240)
|
Full Article (XML)-54K (125)
|
Audio-1072K (14)
|
Peer-Review Report-236K (115)
|
Answering Reviewers-62K (111)
|
Received: 11/09/2023
|
Revised: 12/05/2023
|
Accepted: 12/19/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (6698)
|
Similar Articles (21)
|
Timeline of Article Publication (1)
|
Authors Evaluation (8)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions
World J Hepatol
16(1):17-32.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.17
Abstract (845)
|
Core Tip (677)
|
Full Article (HTML) (7145)
|
Figures (1-2) (555)
|
Tables (1-5) (550)
|
Full Article (PDF)-1655K (302)
|
Full Article with Cover (PDF)-12399K (260)
|
Full Article (XML)-226K (149)
|
Audio-1259K (13)
|
Peer-Review Report-216K (134)
|
Answering Reviewers-145K (126)
|
Received: 09/16/2023
|
Revised: 12/02/2023
|
Accepted: 01/03/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (20)
|
Total Visits (12463)
|
Similar Articles (68)
|
Timeline of Article Publication (1)
|
Authors Evaluation (2)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):33-40.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.33
Abstract (813)
|
Core Tip (729)
|
Full Article (HTML) (3922)
|
Figures (1-1) (550)
|
Full Article (PDF)-601K (307)
|
Full Article with Cover (PDF)-11346K (188)
|
Full Article (XML)-89K (140)
|
Audio-384K (14)
|
Peer-Review Report-180K (121)
|
Answering Reviewers-74K (134)
|
Received: 10/10/2023
|
Revised: 11/06/2023
|
Accepted: 01/05/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (25)
|
Total Visits (8852)
|
Similar Articles (346)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study
World J Hepatol
16(1):41-53.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.41
Abstract (781)
|
Core Tip (696)
|
Article Highlights (710)
|
Full Article (HTML) (2660)
|
Figures (1-4) (492)
|
Tables (1-3) (496)
|
Full Article (PDF)-1672K (192)
|
Full Article with Cover (PDF)-12418K (181)
|
Full Article (XML)-173K (122)
|
Audio-467K (8)
|
Peer-Review Report-182K (115)
|
Answering Reviewers-71K (149)
|
Received: 11/21/2023
|
Revised: 12/18/2023
|
Accepted: 01/09/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (9055)
|
Similar Articles (2125)
|
Timeline of Article Publication (2)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
Metabolic puzzle: Exploring liver fibrosis differences in Asian metabolic-associated fatty liver disease subtypes
World J Hepatol
16(1):54-64.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.54
Abstract (745)
|
Core Tip (753)
|
Article Highlights (864)
|
Full Article (HTML) (2283)
|
Figures (1-3) (569)
|
Tables (1-2) (533)
|
Full Article (PDF)-1874K (200)
|
Full Article with Cover (PDF)-12619K (215)
|
Full Article (XML)-114K (144)
|
Audio-386K (20)
|
Peer-Review Report-233K (137)
|
Answering Reviewers-161K (131)
|
Received: 10/02/2023
|
Revised: 10/22/2023
|
Accepted: 12/18/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (10645)
|
Similar Articles (14)
|
Timeline of Article Publication (4)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Subcellular distribution of prohibitin 1 in rat liver during liver regeneration and its cellular implication
World J Hepatol
16(1):65-74.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.65
Abstract (657)
|
Core Tip (631)
|
Article Highlights (696)
|
Full Article (HTML) (1657)
|
Figures (1-4) (475)
|
Full Article (PDF)-5746K (181)
|
Full Article with Cover (PDF)-16492K (176)
|
Full Article (XML)-96K (134)
|
Audio-3997K (13)
|
Peer-Review Report-192K (124)
|
Answering Reviewers-146K (130)
|
Received: 09/30/2023
|
Revised: 11/03/2023
|
Accepted: 11/28/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (7314)
|
Similar Articles (43)
|
Timeline of Article Publication (1)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease
World J Hepatol
16(1):75-90.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.75
Abstract (729)
|
Core Tip (710)
|
Article Highlights (774)
|
Full Article (HTML) (2840)
|
Figures (1-4) (471)
|
Tables (1-5) (495)
|
Full Article (PDF)-6006K (216)
|
Full Article with Cover (PDF)-16750K (213)
|
Full Article (XML)-200K (125)
|
Audio-376K (9)
|
Peer-Review Report-182K (134)
|
Answering Reviewers-60K (137)
|
Supplementary Material-355K (129)
|
Received: 11/03/2023
|
Revised: 12/11/2023
|
Accepted: 01/02/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (11398)
|
Similar Articles (1967)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Meta-Analysis
Sorafenib plus transarterial chemoembolization vs sorafenib alone for patients with advanced hepatocellular carcinoma: A systematic review and meta-analysis
World J Hepatol
16(1):91-102.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.91
Abstract (662)
|
Core Tip (725)
|
Article Highlights (715)
|
Full Article (HTML) (2001)
|
Figures (1-4) (503)
|
Tables (1-4) (490)
|
Full Article (PDF)-5941K (184)
|
Full Article with Cover (PDF)-16687K (194)
|
Full Article (XML)-115K (132)
|
Audio-187K (10)
|
Peer-Review Report-215K (129)
|
Answering Reviewers-37K (144)
|
Received: 10/20/2023
|
Revised: 11/21/2023
|
Accepted: 12/12/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (8894)
|
Similar Articles (2640)
|
Timeline of Article Publication (3)
|
Authors Evaluation (5)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Report
World J Hepatol
16(1):103-108.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.103
Abstract (703)
|
Core Tip (719)
|
Full Article (HTML) (1777)
|
Figures (1-1) (549)
|
Full Article (PDF)-5068K (205)
|
Full Article with Cover (PDF)-15813K (179)
|
Full Article (XML)-63K (125)
|
Audio-811K (5)
|
Peer-Review Report-266K (133)
|
Answering Reviewers-225K (132)
|
Received: 08/25/2023
|
Revised: 10/24/2023
|
Accepted: 12/12/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (7671)
|
Similar Articles (4495)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Letter to the Editor
Review on article of effects of tenofovir alafenamide and entecavir in chronic hepatitis B virus patients
World J Hepatol
16(1):109-111.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.109
Abstract (699)
|
Core Tip (749)
|
Full Article (HTML) (1756)
|
Full Article (PDF)-325K (152)
|
Full Article with Cover (PDF)-11079K (182)
|
Full Article (XML)-24K (130)
|
Audio-243K (4)
|
Peer-Review Report-215K (101)
|
Answering Reviewers-19K (108)
|
Received: 10/30/2023
|
Revised: 12/04/2023
|
Accepted: 01/12/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (5507)
|
Similar Articles (404)
|
Timeline of Article Publication (5)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
